Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial

Conclusions. These findings support the current World Health Organization recommendation of LPV/r in first-line ART regimens for HIV-infected children.
Clinical Trials Registration. NCT00307151.

Source: Clinical Infectious Diseases - September 25, 2016 Category: Infectious Diseases Authors: Barlow-Mosha, L., Angelidou, K., Lindsey, J., Archary, M., Cotton, M., Dittmer, S., Fairlie, L., Kabugho, E., Kamthunzi, P., Kinikar, A., Mbengeranwa, T., Msuya, L., Sambo, P., Patel, K., Barr, E., Jean-Phillipe, P., Violari, A., Mofenson, L., Palumbo, P. Tags: HIV/AIDS Source Type: research